A report on the size and share of the Hematuria Treatment Market in the industry by 2028

Posted by Prabha Mahajan on September 29th, 2022

According to our latest study on “Hematuria Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Treatment, Indication, Type, and End User,” the market is projected to reach US$ 1,103.61 million by 2028 from US$ 932.89 million in 2021; it is expected to grow at a CAGR of 2.4% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Hematuria is the presence of blood in the urine. Blood can sometimes be found in the urine but is difficult to see; this is known as microscopic hematuria since it can only be seen under a microscope. The need for hematuria treatment has increased as the incidence of chronic renal disease and urinary tract infections has increased. High prevalence of hematuria-associated indications and increasing awareness about treatment options and improving healthcare expenditure are expected to boost the market growth.

Request Copy of Hematuria Treatment Market Growth Report https://www.theinsightpartners.com/sample/TIPRE00004601/

Market leaders operating in the market have undertaken various organic growth strategies in the hematuria treatment market. The hematuria treatment market majorly consists of the players AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaboration.

Based on treatment, the hematuria treatment market is segmented into drugs, therapies, and others. The drugs segment is likely to hold the largest share of the market in 2020. Further, the therapies segment is expected to register the fastest CAGR of 3.0% during 2021 to 2028.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/hematuria-treatment-market

Like it? Share it!

Prabha Mahajan

About the Author

Prabha Mahajan
Joined: September 26th, 2022
Articles Posted: 158

More by this author